Articles with "cd27" as a keyword



Photo by thisisengineering from unsplash

Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering

Sign Up to like & get
recommendations!
Published in 2022 at "Communications Biology"

DOI: 10.1038/s42003-022-03182-6

Abstract: Agonistic CD27 monoclonal antibodies (mAb) have demonstrated impressive anti-tumour efficacy in multiple preclinical models but modest clinical responses. This might reflect current reagents delivering suboptimal CD27 agonism. Here, using a novel panel of CD27 mAb… read more here.

Keywords: receptor clustering; engineering; agonistic cd27; cd27 ... See more keywords
Photo by clovegrove7 from unsplash

Abstract 4690: Hexavalent CD27 agonists show single agent anti-tumor activity and enhanced memory formation in mouse syngeneic tumor models

Sign Up to like & get
recommendations!
Published in 2017 at "Cancer Research"

DOI: 10.1158/1538-7445.am2017-4690

Abstract: Tumor necrosis factor receptor superfamily (TNFRSF) proteins are widely expressed by immune and tumor cells highlighting their importance in multiple locations and phases of the anti-tumor immune response. Apogenix has developed a proprietary technology platform… read more here.

Keywords: hera cd27l; cd27; hera; anti tumor ... See more keywords
Photo by lucabravo from unsplash

CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.

Sign Up to like & get
recommendations!
Published in 2017 at "Blood"

DOI: 10.1182/blood-2016-12-756585

Abstract: The interaction of the tumor necrosis factor receptor (TNFR) CD27 with its ligand CD70 is an emerging target to treat cancer. CD27 signaling provides costimulatory signals to cytotoxic T cells but also increases the frequency… read more here.

Keywords: cd27; cd70 reverse; function; cell ... See more keywords
Photo from wikipedia

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies.

Sign Up to like & get
recommendations!
Published in 2020 at "Blood advances"

DOI: 10.1182/bloodadvances.2019001079

Abstract: CD27, a costimulatory molecule on T cells, induces intracellular signals mediating cellular activation, proliferation, effector function, and cell survival on binding to its ligand, CD70. Varlilumab, a novel, first-in-class, agonist immunoglobulin G1 anti-CD27 antibody, mediates… read more here.

Keywords: cd27; hematologic malignancies; novel first; varlilumab novel ... See more keywords
Photo by robbie36 from unsplash

A phase 1 dose-escalation study of a PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2021.39.15_suppl.2585

Abstract: 2585 Background: CDX-527 is a bispecific antibody (BsAb) targeting PD-L1 and CD27 that is designed to block immune checkpoint PD-L1/PD-1 interactions while providing immune costimulation through CD27 signaling. CD27 is a key immunostimulatory molecule that… read more here.

Keywords: cd27; activity; cdx 527; bispecific antibody ... See more keywords
Photo from wikipedia

Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity

Sign Up to like & get
recommendations!
Published in 2017 at "PLoS ONE"

DOI: 10.1371/journal.pone.0180691

Abstract: Cytomegalovirus (CMV) infection is associated with immune-suppression in immune-compromised hosts and old adults. We previously showed that ex vivo CMV restimulation of peripheral blood mononuclear cells (PBMC) of CMV-seropositive volunteers expanded CD4+CD27-CD28- regulatory T cells… read more here.

Keywords: cd27 cd28; cmv seropositive; cd27; cd4 cd27 ... See more keywords
Photo from wikipedia

Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management

Sign Up to like & get
recommendations!
Published in 2019 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2018.03094

Abstract: The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4+ T-cells producing IFN-γ+… read more here.

Keywords: study; cd27; cd4 cells; cd27 ccr4 ... See more keywords
Photo from wikipedia

CD27+ microparticle interactions and immunoregulation of CD4+ T lymphocytes

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2023.1043255

Abstract: Introduction Aplasia and hematological malignancies are treated with platelet transfusions, which can have major immunomodulatory effects. Platelet concentrates (PCs) contain many immunomodulatory elements, including the platelets themselves, residual leukocytes, extracellular vesicles, such as microparticles (MPs),… read more here.

Keywords: cd27 expression; cd27; cd4; cd27 microparticle ... See more keywords
Photo from wikipedia

Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival

Sign Up to like & get
recommendations!
Published in 2021 at "Frontiers in Medicine"

DOI: 10.3389/fmed.2021.759605

Abstract: Objective This study aimed to identify the programmed death ligand-1 (PDL1, also termed as CD274) and its positively correlated immune checkpoint genes (ICGs) and to determine the immune subtypes of CD274-centered ICG combinations in oral… read more here.

Keywords: expression; correlated cd274; cd274; positively correlated ... See more keywords